Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops.
Twenty-one children (4 to 12 years old) with severe vernal keratoconjunctivitis refractive to treatment with corticosteroid eyedrops and/or 2% disodium cromoglycate (Optic-rom, Fisons) were treated with CsA 2% eyedrops in oil solution. Eighteen patients (86%) experienced a rapid relief of their subjective symptoms three to four days after initiation of treatment. This was accompanied by objective improvement of ocular manifestations and visual acuity within a week. Sixteen of the children (76%) remained controlled during the 6-week period of treatment. However, only five patients (24%) did not need any additional therapy 2 months after discontinuation of the CsA eyedrops. These findings can be interpreted as an indication for the possible involvement of interleukin secretion in the clinical manifestations of vernal keratoconjunctivitis. Alternatively, the beneficial effects of CsA in this disease may be due to a direct effect on the mast cells preventing the release of their mediators.
BenEzra
D
D
Pediatric Ophthalmology and Immunophthalmology Unit, Hadassah University Hospital, Jerusalem.
Matamoros
N
N
Cohen
E
E
D002648:Child; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D003524:Cyclosporins / Q000008:administration & dosage*; D006801:Humans; D009883:Ophthalmic Solutions; D013997:Time Factors
D003524:Cyclosporins; D009883:Ophthalmic Solutions